Landos Biopharma Inc (LABP)
22.21
-0.26
(-1.16%)
USD |
NASDAQ |
May 20, 16:00
Landos Biopharma 1 Year Total Returns (Daily): 646.3% for May 20, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| May 20, 2024 | 646.3% |
| May 17, 2024 | 649.0% |
| May 16, 2024 | 667.7% |
| May 15, 2024 | 645.8% |
| May 14, 2024 | 654.1% |
| May 13, 2024 | 645.9% |
| May 10, 2024 | 646.8% |
| May 09, 2024 | 684.0% |
| May 08, 2024 | 693.0% |
| May 07, 2024 | 664.9% |
| May 06, 2024 | 664.2% |
| May 03, 2024 | 666.7% |
| May 02, 2024 | 709.1% |
| May 01, 2024 | 668.7% |
| April 30, 2024 | 693.3% |
| April 29, 2024 | 699.7% |
| April 26, 2024 | 643.7% |
| April 25, 2024 | 675.5% |
| April 24, 2024 | 689.0% |
| April 23, 2024 | 632.0% |
| April 22, 2024 | 625.7% |
| April 19, 2024 | 626.8% |
| April 18, 2024 | 624.0% |
| April 17, 2024 | 644.4% |
| April 16, 2024 | 642.3% |
| Date | Value |
|---|---|
| April 15, 2024 | 644.0% |
| April 12, 2024 | 669.2% |
| April 11, 2024 | 644.3% |
| April 10, 2024 | 645.0% |
| April 09, 2024 | 643.2% |
| April 08, 2024 | 643.2% |
| April 05, 2024 | 645.2% |
| April 04, 2024 | 659.7% |
| April 03, 2024 | 657.0% |
| April 02, 2024 | 622.1% |
| April 01, 2024 | 624.8% |
| March 28, 2024 | 688.8% |
| March 27, 2024 | 668.3% |
| March 26, 2024 | 713.6% |
| March 25, 2024 | 707.5% |
| March 22, 2024 | 164.5% |
| March 21, 2024 | 195.0% |
| March 20, 2024 | 170.7% |
| March 19, 2024 | 168.8% |
| March 18, 2024 | 157.2% |
| March 15, 2024 | 159.4% |
| March 14, 2024 | 142.7% |
| March 13, 2024 | 148.2% |
| March 12, 2024 | 134.1% |
| March 11, 2024 | 124.0% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-98.47%
Minimum
Nov 09 2022
713.6%
Maximum
Mar 26 2024
-4.83%
Average
-79.80%
Median
Mar 31 2023
1 Year Total Returns (Daily) Benchmarks
| AbbVie Inc | 18.03% |
| Fusion Pharmaceuticals Inc | 401.9% |
| Masimo Corp | -22.52% |
| Kinnate Biopharma Inc (DELISTED) | -- |
| Invivyd Inc | 81.45% |